Ypsomed Holding AG (YPHDF)

Market Cap	5.30B -2.6%
Revenue (ttm)	987.67M +27.6%
Net Income	243.29M +160.8%
EPS	17.82 +160.7%
Shares Out	n/a
PE Ratio	21.78
Forward PE	22.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	62
Average Volume	66
Open	376.85
Previous Close	393.47
Day's Range	374.82 - 376.85
52-Week Range	362.28 - 535.75
Beta	0.94
RSI	53.16
Earnings Date	Feb 11, 2026

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: YPHDF

Financial Performance

In fiscal year 2025, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.

Financial numbers in CHF